Development and External Validation of a Model to Predict Complex Treatment After Radiofrequency Ablation for Barrett's Esophagus With Early Neoplasia.

Sanne N van Munster,Esther Nieuwenhuis,Raf Bisschops,Hilde Willekens,Bas L A M Weusten,Lorenza Alvarez Herrero,Auke Bogte,Alaa Alkhalaf,Ed B E Schenk,Erik J Schoon,Wouter Curvers,Arjun D Koch,Pieter Jan F de Jonge,Tjon J Tang,Wouter B Nagengast,Jessie Westerhof,Martin H M G Houben,Jacques J G H M Bergman,Roos E Pouw

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association（2022）

引用 4|浏览16

暂无评分

摘要

We developed a prognostic model that identified patients with a BE length of 9 cm or longer and high-grade dysplasia/esophageal adenocarcinoma and those with poor squamous regeneration as high risk for a complex treatment course. The good performance in external validation suggests that it may be used in clinical management (Netherlands Trial Register: NL7039).

查看译文

关键词

Barrett’s Esophagus,Endoscopic Therapy,Esophageal Adenocarcinoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要